Iatrogenic Cerebral Amyloid Angiopathy is a rare but serious condition that may only become apparent decades after neurosurgical treatment. Its delayed onset and complex causes can leave families searching for answers. If you are concerned that past medical care may have contributed to neurological harm, Calio can provide clear, confidential legal advice.
Contact our team today by completing the online contact form to discuss your situation and understand your options.
Iatrogenic Cerebral Amyloid Angiopathy: A hidden risk in neurosurgical practice
Iatrogenic Cerebral Amyloid Angiopathy (ICAA) is an emerging concern in neurology and neurosurgery, linked to the inadvertent transmission of amyloid-beta proteins during surgical procedures. While rare, its implications for patient safety and medico-legal accountability are profound.
What is ICAA?
ICAA occurs when amyloid-beta deposits accumulate in cerebral blood vessels following exposure to contaminated surgical instruments or graft materials, such as cadaveric dura mater. This mechanism mirrors prion-like propagation, raising alarm about historical neurosurgical practices.
Clinical presentation
Patients typically present decades after the initial procedure with symptoms including:
- Recurrent lobar haemorrhages
- Cognitive decline
- Seizures
The long latency period complicates diagnosis and often delays recognition.
Diagnostic challenges
MRI scans may reveal cortical microbleeds and superficial siderosis, but definitive diagnosis requires histopathological confirmation. Clinicians should maintain a high index of suspicion in patients with prior neurosurgical history.
Legal and ethical implications
The discovery of iatrogenic transmission introduces significant medico-legal considerations:
- Were sterilisation protocols adequate?
- Was informed consent comprehensive regarding long-term risks?
Under Scottish Law, healthcare providers owe a duty of care to prevent foreseeable harm. Failure to adhere to infection control standards could constitute negligence.
Types of potential claims
- Loss of society and support: Compensation for dependants affected by premature death.
- Medical and care costs: Recovery of expenses linked to prolonged illness.
- Pain and suffering: Damages for distress endured by the patient.
What should you do if a loved one is affected?
If you suspect ICAA in a family member, seek expert legal advice promptly. At Calio, we can:
- Review surgical and medical records
- Obtain independent neurological opinions
- Advise on the viability of a claim
Our team understands the complexity and emotional toll of such cases. We are committed to guiding you through the process with compassion and professionalism.
Frequently Asked Questions
It is a condition caused by accidental exposure to amyloid beta proteins during medical procedures.
Symptoms may develop several decades after the original neurosurgical treatment.
Not always, but failures in sterilisation or consent may give rise to a claim.
Recurrent brain haemorrhages, cognitive decline, and seizures are common features.
Yes, early advice can help assess whether a medical negligence claim is possible.
Contact Calio Claims
If you believe that you or a loved one may have been affected by iatrogenic cerebral amyloid angiopathy following neurosurgical treatment, Calio is here to help. Call 0800 988 8082 or complete our online contact form to speak with an experienced clinical negligence solicitor in confidence.
